Stocks
G1 Therapeutics (GTHX) EBITDA US GAAP (year values) |
||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | |||
| EBITDA, bln rub | ? | 0.000 | -95.5 | -142.5 | -134.9 | -34.3 | -33.5 | |
| Changes by years, y/y, % | +49% | -5% | -75% | |||||
G1 Therapeutics. EBITDA US GAAP, bln rub
G1 Therapeutics. EBITDA US GAAP, changes, %
G1 Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
G1 Therapeutics (GTHX) EBITDA US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 12.9 | -15.1 | -7.73 | -8.12 | -2.62 | -33.5 | |
| Changes by years, y/y, % | -135% | -29% | -74% | -67% | -120% | |||
| Changes by quarters, q/q, % | -153% | -217% | -49% | +5% | -68% | |||
